 The major disadvantages of vaccine efficacy trials are the complexity and expense of performing them, especially for relatively uncommon infectious outcomes of diseases for which the sample size required is driven up to achieve clinically useful statistical power.Vaccine efficacy is calculated on a population basis.It is therefore relatively easy to misunderstand its application.